| Treatment of Tinnitus | MED205.022 · Effective Aug 1, 2026 · Commercial, Medicaid | 7 | Original policy ↗ |
| Triamcinolone acetonide | OTH903.035 · Commercial, Medicaid | 3 | Original policy ↗ |
| Tumor Treating Fields (TTF) Therapy | MED201.039 · Commercial, Medicaid | 3 | Original policy ↗ |
| Ublituximab-xiiy | RX501.153 · Commercial, Medicaid | 1 | Original policy ↗ |
| Ultrafiltration in Decompensated Heart Failure | MED202.062 · Commercial, Medicaid | 1 | Original policy ↗ |
| Ultrasonic Osteogenesis Stimulator | DME101.030 · Commercial, Medicaid | 2 | Original policy ↗ |
| Unbundling Policy-Professional Providers | CPCP034 · Effective Jan 19, 2026 · Commercial, Medicaid · OK | — | Original policy ↗ |
| Unicondylar Interpositional Spacer as a Treatment of Unicompartmental Arthritis of the Knee | SUR705.024 · Effective Apr 1, 2026 · Commercial, Medicaid | 3 | Original policy ↗ |
| Unlisted/Not Otherwise Classified (NOC) Coding Policy | RP035 · Effective Aug 14, 2026 · Commercial, Medicaid · OK | 14 | Original policy ↗ |
| Urinary Tumor Markers for Bladder Cancer | RPLAB038 · Effective Sep 4, 2026 · Commercial, Medicaid · OK | 17 | Original policy ↗ |
| Urine Culture Testing for Bacteria | CPCPLAB050 · Effective Jan 3, 2026 · Commercial, Medicaid · OK | 8 | Original policy ↗ |
| Urine Culture Testing for Bacteria | RPLAB050 · Effective Dec 4, 2026 · Commercial, Medicaid · OK | 8 | Original policy ↗ |
| Use of a Medial Knee Implantable Shock Absorber | SUR705.051 · Commercial, Medicaid | 3 | Original policy ↗ |
| Ustekinumab and Associated Biosimilars | RX501.114 · Effective Jul 1, 2026 · Commercial, Medicaid | 15 | Original policy ↗ |
| Uterus Transplantation for Absolute Uterine Factor Infertility | OB402.035 · Effective May 1, 2026 · Commercial, Medicaid | 7 | Original policy ↗ |
| Vagus Nerve Stimulation (VNS) | SUR712.021 · Effective Aug 15, 2026 · Commercial, Medicaid | 29 | Original policy ↗ |
| Valoctocogene Roxaparvovec-rvox | RX501.128 · Effective Jan 1, 2026 · Commercial, Medicaid | 1 | Original policy ↗ |
| Varicose Vein Management | SUR707.016 · Commercial, Medicaid | 27 | Original policy ↗ |
| Vedolizumab | RX501.117 · Commercial, Medicaid | 1 | Original policy ↗ |
| Venous and Arterial Thrombosis Risk Testing | RPLAB058 · Effective Sep 4, 2026 · Commercial, Medicaid · OK | 7 | Original policy ↗ |
| Ventricular Assist Devices and Total Artificial Hearts | SUR707.017 · Commercial, Medicaid | 52 | Original policy ↗ |
| Vertebral Axial Decompression | THE803.021 · Effective Sep 15, 2026 · Commercial, Medicaid | 3 | Original policy ↗ |
| Vertical Expandable Prosthetic Titanium Rib | SUR705.025 · Commercial, Medicaid | 1 | Original policy ↗ |
| Vestibular Function Testing | MED201.047 · Commercial, Medicaid | 13 | Original policy ↗ |
| Viscocanalostomy and Canaloplasty | SUR713.032 · Commercial, Medicaid | 3 | Original policy ↗ |
| Vitamin B12 and Methylmalonic Acid Testing | CPCPLAB010 · Effective May 1, 2026 · Commercial, Medicaid · OK | 4 | Original policy ↗ |
| Vitamin D Testing | CPCPLAB003 · Effective May 1, 2026 · Commercial, Medicaid · OK | 3 | Original policy ↗ |
| Vutrisiran (Amvuttra) and Patisiran (Onpattro) | RX501.146 · Effective Jan 1, 2026 · Commercial, Medicaid | 2 | Original policy ↗ |
| Wasted/Discarded Drugs and Biologicals Guideline | RP017 · Effective Aug 28, 2026 · Commercial, Medicaid · OK | 2 | Original policy ↗ |
| Wheelchairs and Accessories | DME101.010 · Effective Jan 1, 2026 · Commercial, Medicaid | 366 | Original policy ↗ |
| Wilate | RX501.160 · Commercial, Medicaid | 1 | Original policy ↗ |
| Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders | RAD601.042 · Effective Aug 1, 2026 · Commercial, Medicaid | 5 | Original policy ↗ |
| Zopapogene imadenovec-drba | RX501.183 · Commercial, Medicaid | 2 | Original policy ↗ |
| β-Hemolytic Streptococcus Testing | CPCPLAB053 · Effective Jan 3, 2026 · Commercial, Medicaid · OK | 19 | Original policy ↗ |